Circulating ESM-1 levels are correlated with the presence of coronary artery disease in patients with obstructive sleep apnea

Abstract

BackgroundEndothelial dysfunction is one of the most important early indicators of atherosclerosis in obstructive sleep apnea (OSA) patients. Endothelial cell specific molecules-1 (ESM-1), which is a novel endothelial dysfunction marker that may be linked to cardiovascular disease. We investigated to assess whether circulating ESM-1 levels are correlated with the presence of coronary artery disease (CAD) in patients with OSA.MethodsWe performed a cross-sectional study in 228 Chinese OSA subjects, including 185 patients with OSA and 43 controls. The Gensini stenosis scoring system was used to assess the severity of CAD. Circulating ESM-1 levels were measured by Human Magnetic Luminex Screening Assay. The associations between circulating ESM-1 levels and CAD were determined by multivariate logistic regression analysis. The association between ESM-1 levels and Gensini scores was determined by multivariate linear regression analysis.ResultsCAD patients had significantly higher circulating ESM-1 levels compared with non-CAD patients (1279.01[918.52–1770.71] pg/ml vs 585.46[423.61–812.56] pg/ml, P\u2009<\u20090.001). After adjusting for confounding factors, we found that circulating ESM-1 levels were an independent risk factor for CAD (OR\u2009=\u20091.633/100\u2009pg ESM-1, 95%CI =1.179–2.262, P\u2009=\u20090.003), while circulating ESM-1 levels have no significant correlation with the Gensini score. Furthermore, circulating ESM-1 showed higher discriminatory accuracy in predicting the presence of OSA (AUC:0.910).ConclusionsCirculating ESM-1 might function as a useful biomarker for monitoring the development and progression of CAD in OSA patients.